Silver Book Fact

The greater use of medications and revascularization would provide approximately a 17% reduction in 2 year mortality combined.

Rosen, Allison B., David M. Cutler, Douglas M. Norton, Hsou Mei Hu, and Sandeep Vijan. The Value Of Coronary Heart Disease Care For The Elderly: 1987-2002. Health Affairs. 2007; 26(1): 111-123

Reference

Title
The Value Of Coronary Heart Disease Care For The Elderly: 1987-2002
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Rosen, Allison B., David M. Cutler, Douglas M. Norton, Hsou Mei Hu, and Sandeep Vijan
Volume & Issue
Volume 26, Issue 1
Pages
111-123

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Since 1970, reduced mortality from heart disease has increased the value of life by about $1.5 trillion per year. The value of improvements in health care over the 20th century…  
  • Medicines Produce Valuable Health Gains for Heart Attack Patients  
  • TAVR v. SAVR in Intermediate-Risk SAS Patients
    At 1-year, severe aortic stenosis (SAS) patients with intermediate surgical mortality risk who underwent transcatheter aortic valve replacement (TAVR), had all-cause mortality rates of 7.4% (compared to 13% for surgical…  
  • If antihypertensive medication were widely used, it would result in an estimated increase in life expectancy (averaged over the entire population) of 0.5 years in men and 0.4 years in…  
  • The projected economic value of eliminating deaths from stroke is $7.6 trillion.